Discovery and Development of Medicines

Course content

The topics taught are:

  • Target evaluation and biopharmaceuticals
  • Identification of lead structures
  • Medicinal chemistry: Lead optimization and synthesis
  • Non-clinical safety
  • Animal biology and pharmacology
  • Preformulation
  • Pharmaceutical formulation
  • Clinical trials
  • Quality assurance
  • Regulatory affairs
  • Production
  • Marketing
Education

Master's Programme in Industrial Drug Development - compulsory

 

See course calendar for course dates on the webpage for Master of Industrial Drug Development  

Compulsory for Master of Industrial Drug Development (MIND) students and Master of Medicines Regulatory Affairs (MRA) students.

Elective for other part-time master's students at the Faculty of Health and Medical Sciences (subject to study board approval) and open for freelance students who meet the admission criteria.

The course is intended for drug development professionals and regulatory affairs professionals who need an overview of the entire drug discovery and development process, or professionals who need a brush-up course for continuing professional development (CPD).

Learning outcome

People involved in the development of medicines have diverse educational backgrounds. Often their basic academic educations have not at all touched upon discovery and development of medicines. This course aims to convey knowledge of drug discovery and development in general to the participants so they may communicate across the different fields of the process.

On completion of the course, participants will have comprehensive overview of drug discovery and development and a sound grasp of the fundamentals of the major implicated disciplines. Participants will be able to convey an understanding of the dynamics of the drug discovery and development and communicate across research fields.

Upon completion of the course, participants are expected to be able to:

Knowledge

  • give a comprehensive overview of discovery and development of medicines
  • identify correct professional terms in discovery and development of medicines
  • list major steps and elements of the drug development process
  • outline definitions of key concepts and the fundamentals of the major disciplines in drug discovery and development
  • identify the important transition points that require involvement of authorities


Skills

  • appraise the integration of the various basic disciplines into the process of discovery and development of medicines
  • analyse the sequence and flow of the various steps in the process of drug discovery and development
  • plan a development process within the regulatory framework


Competencies

  • liaise with all steps of drug discovery and development
  • identify critical factors and bottlenecks that influence the drug development process
  • promote and state milestones for the progress of the development of a medical product
  • communicate professionally with the various specialist groups within the industrial area of development of medicines

The course is organized as an intensive 10-day course and comprises lectures, group discussions, presentations and discussions. In order to emphasize the flow of the process, the course is to a large extent based on the use of cases in both lectures and assignments.

The syllabus comprises collections of review papers, textbook chapters and case stories and updated lecture slides, corresponding to approximately 500 pages. All material will be distributed electronically either placed on the course homepage or as an USB. 

Participants are expected to purchase: Drug Discovery and Development. Technology in Transition, 2nd edition Humphrey P. Rang, Churchill Livingstone, 978-0443064203. Avalable also as E-Book.

The Textbook of Pharmaceutical Medicine, 7th edition, 2013. John P. Griffin (Editor), John Posner (Editor), Geoffrey R. Barker (Editor) Blackwell BMJ Books serves as “nice to know” and it is used in other MIND courses.

Applicants must meet the following criteria:
• A relevant bachelor degree or equivalent
• A minimum of 2 years of relevant job experience
• Proficiency in English

Oral
Continuous feedback during the course of the semester
ECTS
5 ECTS
Type of assessment
Written examination, 2 hours under invigilation
Type of assessment details
Examination design: The test is composed of essay questions and multiple choice questions.The purpose of the examination is to test that the examinee has achieved the expected learning outcomes. The percentage of items in the test devoted to a particular topic will roughly correspond to the emphasis given the topic in teaching of the course:
• Discovery: 20 %
• Non-clinical (exploratory) development: 50 %
• Clinical development: 30 %
Aid
Written aids allowed

Find more information about written on-site exams in the exam rooms, incl. information about standard programs on the exam PCs at KUnet - Study Information - Exam types and rules - Written on-site exam (ITX). 

 

Marking scale
7-point grading scale
Censorship form
External censorship
Criteria for exam assessment

The examination will monitor the knowledge and skills of the participants using the following criteria:

Knowledge

  • the ability to give a comprehensive overview of discovery and development of medicines
  • the ability to identify correct professional terms in discovery and development of medicines
  • the capability to list major steps and elements of the drug development process
  • the capability to outline definitions of key concepts and the fundamentals of the major disciplines in drug discovery and development
  • the ability to identify the important transition points that require involvement of authorities


Skills

  • the understanding of the integration of the various basic disciplines into the process of discovery and development of medicines
  • the skill to analyse the sequence and flow of the various steps in the process of drug discovery and development
  • the ability to plan a development process within the regulatory framework

 

 

Part time Master and Diploma courses

  • Category
  • Hours
  • Lectures
  • 40
  • Preparation
  • 78
  • Theory exercises
  • 20
  • Exam
  • 2
  • English
  • 140

Kursusinformation

Language
English
Course number
SMIMB1011U
ECTS
5 ECTS
Programme level
Part Time Master
Duration
5 + 5 days
Placement
Autumn And Spring
Price

EU/EEA citizens: DKK 21,500. (Non EU/EEA citizens please see MIND-page). Fee includes course materials and lunch/coffee. Prices may be subject to change. Textbook must be purchased by the participants.

Schedulegroup
see course calendar
Capacity
36 participants
Studyboard
Study Board for the Professionel Master´s Degree Programmes at The Faculty og Health and Medical Science
Contracting department
  • Department of Drug Design and Pharmacology
Contracting faculty
  • Faculty of Health and Medical Sciences
Course Coordinator
  • Anders Bach   (11-6b786e6f7c7d386c6b6d724a7d7f786e38757f386e75)
Teacher

This list of lecturers may be subject to change.

Søren Østergaard
Mads Grønborg
Julie Kaae Klint
Søren Møller Nielsen
Anette Graven Sams
Dorte Kold Jensen
Anders Lohse
Per Rexen
Morten Dahl Sørensen
Helle Northeved
Klaus Gjervig Jensen
Frank Larsen
Jesper F Bastlund
Benjamin Hall
Heidi Lopez de Diego
Jette Bisgaard Boll
Lars Hovgaard
Erik Skibssted
Petteri Heljo
Tue Hansen
Louise Bastholm Jensen
Anette Torstenson
Karina Nymark
Sidse Schjøtz
Stine Kihl-Plambek
Christian Bressen Pipper
Gitte Dyhr
Dorte Bjørn-Larsen
Anette Hjelmsmark
Troels V. Christensen
Anders Krabbe

Saved on the 23-03-2022

Are you BA- or KA-student?

Are you bachelor- or kandidat-student, then find the course in the course catalog for students:

Courseinformation of students